Supernus Inc SUPN

$28.51 -0.45 (-1.55%)

Valuation

Market cap
3,427,737,000
Revenue TTM
$1,239,000,000
Net income TTM
$210,000,000
P/E (trailing)
6.78
P/E (forward)
7.59
Profit margin
16.95%
Debt to equity
-8.13

Trading

Volume
776,186
Avg volume
2,989,726
Day's range
$28.33 – $29.37
Shares out
118,035,000
Stochastic %K
71%
Beta
0.84
Analysts
Strong Buy
Price target
$49.89

Price

Company profile

Supernus, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly...

Show more

Supernus, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Supernus, Inc. was formerly known as Indivior Pharmaceuticals, Inc. and changed its name Supernus, Inc. in November 2026. Supernus, Inc. was incorporated in 2014 and is headquartered in Rockville, Maryland.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Phone
(301) 838-2500
Website
https://www.supernus.com
Address
9715 Key West Avenue, Rockville, United States

Latest news

No headlines yet.